Waukesha, Wis.-based GE Healthcare has introduced new digital mammography technology to enable earlier detection and diagnosis of cancer in the densest parts of breast tissue. The Food and Drug Administration has not yet approved the technology.

The SenoBright Contrast Enhanced Spectral Mammography technology works like the rapid flashes of a digital camera to reduce red-eye in photographs. It uses X-rays at multiple energies to create two separate exposures. Resulting images illuminate and highlight areas were there is angiogenesis, which is the growth of small blood vessels potentially related to the presence of cancer.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access